Cart is empty Researchers at the University of São Paulo (USP) in Brazil, partnering with Foresee Pharmaceuticals, a Taiwan and US-based biopharmaceutical company, have tested a synthetic molecule for the treatment of heart failure. The study has been published in the European Heart Journal. The theme was also highlighted in the magazine’s editorial.
Leave A Comment